Negative Pressure Wound Therapy and Skin Graft in Madura Foot Treatment

Year 2012, Volume: 2012 Issue: 2, 214 - 217, 01.02.2012

Ali Murat Kalender Halit Baykan Fuat Özkan Harun Çıralık Perihan Öztürk Mustafa Gül Hasan Uçmak

https://doi.org/10.5152/balkanmedj.2012.014

Abstract

Madura foot is a rare, loca, chronic granulomatous skin infection which commonly affects the adult male foot. Medical treatment reduces the size of the lesion but surgical excision is necessary for radical treatment. We present a case of a 59 year old male farmer diagnosed as actinomadura of the right foot treated with medical treatment, total excision, negative pressure wound therapy and split thickness skin graft. Turkish Başlık: Madura Ayağı Tedavisinde Negatif Basınçlı Yara Tedavisi ve Cilt Grefti. Olgu Sunumu ve Literatürün Gözden Geçirilmesi Anahtar Kelimeler: Madura ayağı, negatif basınçlı yara tedavisi, bölünmüş kat deri grefti Madura ayağı nadir görülen genellikle erişkin erkekleri etkileyen lokal kronik granulomatoz bir deri enfeksiyonudur. Medikal tedavi lezyonların küçülmesine sebep olur ancak radikal tedavi için cerrahi eksizyon gereklidir. Biz sağ ayağında aktinomadura tanısı ile medikal tedavi, total eksizyon, negatif basınçlı yara tedavisi ve ardından bölünmüş kat deri grefti ile tedavi edilen 59 yaşında erkek çiftçi hasta sunduk.

Keywords

Madura foot, negative pressure wound therapy, split thickness skin graft

Negative Pressure Wound Therapy and Skin Graft in Madura Foot Treatment

Abstract

References

• Ahmed AO, van Leeuwen W, Fahal A, van de Sande W, Verbrugh H, van Belkum A. Mycetoma caused by madurella mycetomatis: a neglected infectious burden. Lancet 2004;4:566-74. [CrossRef]
• Burkus JK. Primary mycetoma infection of the distal tibia second- ary to an occult foreign body. Foot Ankle 1985;6:47-52.
• Fahal AH, Hassan MA. Mycetoma Br J Surg 1992;79:1138-41. [CrossRef]
• Ahmed A, Adelmann D, Fahal AH, Verbrugh H, van Belkum A, de Hoog S. Environmental occurrence of Madurella mycetomatis, the major agent of human eumycetoma in Sudan. J Clin Micro- biol 2002;40:1031-6. [CrossRef]
• Fahal AH, Suliman SH, Gadir AFA, El Hag IA, El Amin FI, Gumaa SA, et al. Abdominal wall mycetoma: unusual presentation. Trans. R Soc Trop Med Hyg 1994;88:78-80. [CrossRef]
• Fahal AH. Mycetoma: a thorn in the flesh. Trans R Soc Trop Med Hyg 2004;98:3-11. [CrossRef]
• Gumaa SA, Mahgoub ES, El Sid MA. Mycetoma of the head and neck. Am J Trop Med Hyg 1986;35:596-600.
• McElroy JA, Prestes CD, Su WP. Mycetoma: infection with tume- faction, draining sinuses, and “grains.” Cutis 1992;49:107-10.
• Young BA, Fee MJ, Giacopelli JA, Granoff DP, Kobayashi W. My- cetoma J Am Podiatr Med Assoc 2000;90:81-4.
• El Hag IA, Fahal AH, Khalil EAG. Fine nee-dle aspiration cytology of mycetoma. Acta Cytol 1996;40:461-4. [CrossRef]
• Mahgoub ES. Medical treatment of mycetoma in the Sudan. Su- dan Med J 1994;32:88-97.
• Ahmed AO, van de Sande WJ, Verbrugh H, Fahal A, van Belkum A. Madurella mycetomatis strains from mycetoma lesions in Sudanese patients are clonal. J Clin Microbiol 2003;41:4537-41. [CrossRef]
• Ahmed AO, van Leeuwen W, Fahal A, van de Sande W, Verbrugh H, van Belkum A. Mycetoma caused by Madurella mycetomatis: a ne- glected infectious burden. Lancet infect Dis 2004;4:566-74. [CrossRef]
• Cipolla J, Baillie DR, Steinberg SM, Martin ND, Jaik NP, Lukaszc- zyk JJ, et al. Negative pressure wound therapy: Unusual and in- novative applications. OPUS 12 Scientist 2008;2:15-29.
• Van der Velde M, Hudson DA. VADER (vacuum-assisted dermal recruitment): a new method of wound closure. Ann Plast Surg 2005;55:660-4. [CrossRef]
• Weed T, Ratliff C, Drake DB. Quantifying bacterial bioburden during negative pressure wound therapy: does the wound VAC enhance bacterial clearance? Ann Plast Surg 2004; 52:279-80. [CrossRef]
• Jones JE, Nelson EA. Skin grafting for venous leg ulcers. Co- chrane Database Syst Rev 2007;18:CD001737.
• Sarris I, Berendt AR, Athansous N, Ostlere SJ. MRI of mycetoma of the foot: two cases demonstrating the dot-in-circle sign. Skel- etal Radiol 2003;32:179-83.